Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of MEDX's 30 holdings also in PPH
41.7%
% of PPH's 27 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.9% | 11.7% | 11.7% |
|
ABBVIE INC | 7.8% | 5.9% | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.2% | 5.5% | 5.2% |
|
JOHNSON & JOHNSON | 5.2% | 6.6% | 5.2% |
|
MERCK & CO. INC. | 5.2% | 6.3% | 5.2% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PPH
|
AMGEN INC | 5.5% |
|
REGENERON PHARMACEUTICALS | 3.9% |
|
BIOGEN IDEC INC | 3.7% |
|
CRISPR THERAPEUTICS AG | 3.6% |
 |
ALKERMES PLC | 3.4% |
|
ELI LILLY & CO | 3.2% |
|
IONIS PHARMACEUTICALS, INC. | 3.1% |
|
ALNYLAM PHARMACEUTICALS INC | 2.5% |
|
ABBVIE INC | 1.9% |
|
INTELLIA THERAPEUTICS, INC. | 1.9% |
MEDX Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -9.6% |
|
AMERISOURCEBERGEN CORP | -4.8% |
|
MCKESSON CORP | -4.7% |
 |
SANOFI-AVENTIS-ADR | -4.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.3% |
|
ZOETIS INC | -3.8% |
 |
TEVA PHARMACEUTICAL-SP ADR | -2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -1.7% |
|
VIATRIS, INC. | -1.6% |
|
JOHNSON & JOHNSON | -1.4% |